Cervical Arthroplasty vs Fusion for Single-Level Cervical Disc Disease
For a 45-year-old healthy adult with single-level cervical disc disease, intact facet joints, no instability or osteoporosis, cervical arthroplasty (artificial disc replacement) is superior to ACDF and should be recommended as the preferred surgical option. 1, 2
Evidence Supporting Arthroplasty Superiority
Long-Term Clinical Outcomes
At 10 years, cervical disc arthroplasty demonstrates statistically superior composite success rates compared to ACDF (62.4% vs 22.2%, p<0.0001), representing a nearly 3-fold advantage in overall clinical success. 2
The cumulative risk of subsequent surgery at 10 years is dramatically lower with arthroplasty versus fusion (7.2% vs 25.5%, p=0.001), meaning ACDF patients face more than triple the reoperation risk. 2
Adjacent-level surgery rates are significantly reduced with arthroplasty (3.1% vs 20.5%, p=0.0005), demonstrating that motion preservation substantially protects neighboring segments from accelerated degeneration. 2
Adjacent Segment Protection
Radiographically significant adjacent-segment pathology progression at 10 years occurs in only 12.9% of arthroplasty patients compared to 39.3% of fusion patients (p=0.006), providing objective evidence that motion preservation reduces biomechanical stress on adjacent levels. 2
The concern that fusion contributes to accelerated adjacent segment degeneration was the primary driver for developing cervical disc replacement technology, and long-term data now validates this concern. 3
Patient Satisfaction and Functional Outcomes
Patient satisfaction is significantly higher with arthroplasty, with 98.7% reporting "very satisfied" at 10 years versus 88.9% with ACDF (p=0.05). 2
Patient-reported outcomes and change from baseline are generally better in arthroplasty patients across multiple validated measures including Neck Disability Index, neck and arm pain scores, and SF-12. 2
For single-level disease specifically, arthroplasty demonstrates superior neurological success (OR 1.92; 95% CI 1.47-2.49; p<0.00001), better range of motion preservation (MD 6.67°; 95% CI 4.82-8.53; p<0.00001), and reduced secondary surgical procedures (OR 0.50; 95% CI 0.37-0.68; p<0.00001) at 24 months. 4
Guideline-Based Patient Selection Criteria
Mandatory Prerequisites Before Surgery
Complete a minimum 6-week trial of structured conservative therapy including formal physical therapy, anti-inflammatory medications, activity modification, and possible cervical collar immobilization, unless progressive neurological deficits are present. 1, 5, 6
Document that 75-90% of cervical radiculopathy patients improve with conservative management, making premature surgical intervention inappropriate. 1
Confirm clinical correlation between imaging findings (moderate-to-severe foraminal stenosis or disc herniation) and symptoms (dermatomal pain, sensory changes, motor weakness). 1, 5
Specific Contraindications to Arthroplasty
Obtain flexion-extension radiographs to definitively rule out segmental instability before proceeding with arthroplasty, as static MRI cannot adequately assess dynamic instability. 1
Exclude recent postoperative infection, which represents an absolute contraindication to artificial disc placement due to unacceptable risk of recurrent infection and implant failure. 1
Verify absence of adjacent level disease after recent fusion, as this is not FDA-approved for arthroplasty and lacks long-term outcome data. 1
Document bone density assessment to exclude osteoporosis, which compromises implant stability and fusion success rates. 1
Confirm intact facet joints without significant arthropathy, as facet degeneration is a contraindication to motion-preserving surgery. 1
Real-World Clinical Outcomes
Comparative Safety Profile
Registry data from the Michigan Spine Surgery Improvement Collaborative demonstrates similar complication rates and functional outcomes between ACDF and CDA at 2 years in real-world practice, confirming that arthroplasty safety matches fusion in routine clinical settings outside strict clinical trial protocols. 7
Length of stay is shorter with arthroplasty (1.0 vs 1.3 days, p<0.001), and the procedure is more frequently performed as outpatient surgery. 7
Adverse event rates are equivalent between arthroplasty and fusion (RR 0.93; 95% CI 0.76-1.15; p=0.52), demonstrating comparable safety profiles. 4
Operative Considerations
Operation time is longer for arthroplasty (approximately 90 minutes longer for two-level procedures), but this difference is not clinically significant given the superior long-term outcomes. 8
Blood loss is comparable between procedures (MD 6.92 mL; 95% CI -3.09 to 16.92 mL; p=0.18). 4
Critical Decision Algorithm
When to Choose Arthroplasty (Preferred)
Age <60 years with single-level disease, intact facet joints, no instability on flexion-extension films, normal bone density, and failed 6-week conservative trial. 1, 2, 7
Patient prioritizes motion preservation and accepts slightly longer operative time in exchange for dramatically reduced adjacent segment disease and reoperation risk. 2
No contraindications present (instability, infection history, osteoporosis, severe facet arthropathy, adjacent level disease). 1
When ACDF Remains Appropriate
Presence of any absolute contraindication to arthroplasty listed above. 1
Patient age >60-65 years where adjacent segment disease risk is less relevant due to shorter life expectancy. 3
Multilevel disease (>2 levels), though two-level arthroplasty shows similar outcomes to fusion. 8
Documented segmental instability on flexion-extension radiographs. 1
Common Pitfalls to Avoid
Never proceed to surgery without documenting 6 weeks of formal conservative therapy unless progressive neurological deficits are present, as 75-90% of patients improve without surgery. 1, 5
Never rely on static MRI alone to exclude instability; flexion-extension radiographs are mandatory before arthroplasty. 1
Never ignore the 3-fold higher reoperation rate with ACDF when counseling patients about long-term outcomes. 2
Never assume equivalent outcomes based on short-term data; the superiority of arthroplasty becomes increasingly apparent beyond 5 years. 2
Never perform arthroplasty in patients with osteoporosis or significant facet arthropathy, as these compromise implant stability and motion preservation benefits. 1